New Haven, CT · Founded 2023 · Privately Held (backing)
Developer of a Ribonucleic Acid (RNA) therapeutics development platform designed to revolutionize cancer therapy and patient outcomes in oncology. Cloverleaf Bio is based in New Haven, CT and was founded in 2023. It has raised $1.1 million.
Last price · $/share
—
Implied valuation
—
Total raised
$1.1M
Last round
—
Cap table — not yet on record
Cloverleaf Bio's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Private Market View
More of Cloverleaf Bio with a free Private Market View account
·Watch Cloverleaf Bio: the Monday email on marks, rounds and moves
